About Us

With years of core technological advantages in antigen preparation, antibody development, recombinant antibody production, antibody engineering, material synthesis and chemical labeling, the company has built a new-generation R&D and production platform for monoclonal antibodies. It cooperates with famous medical institutions and pathology experts at home and abroad to conduct antibody screening, clinical pathological diagnosis evaluation and quality control in accordance with international standards, and has developed a full range of IHC primary and secondary antibodies with proprietary clone numbers.

Myabtech Biological Inc. focuses on the R&D and production of a full range of IHC antibodies and supporting reagents, and is committed to becoming a famous global supplier of IHC antibody raw materials!